Neoadjuvant or adjuvant chemoradiation
The indication for chemoradiation therapy was the same in both groups. Patients with UICC stage II or III were treated adjuvantly up to 2005 and neoadjuvantly thereafter. The rectal cancer staging required for neoadjuvant therapy was performed by MRI, and endosonography was also used whenever possible.
Treatment was identical in both groups. Radiotherapy consisted of single doses of 1.8 Gy, five times a week, up to a total of 50.4 Gy, delivered (as at least 6-MV photons) in 28 fractions to the pelvis with individual CT-based shaped portals and using of a three-field or four-field box technique. Patients were treated in prone position with a special device ("belly board") to reduce the dose to the small bowel. The anal sphincter was included in the target volume if the tumor was located in the distal or middle third of the rectum. Fluorouracil (5-FU) was given simultaneously as a continuous infusion with a dose of 225 mg/m 2 /d throughout the whole treatment, weekends included. The initiation of adjuvant chemoradiation was planned 4 to 6 weeks after the operation (Group I), as the operation was performed 4 to 6 weeks following neoadjuvant chemoradiation (Group II).
Surgical procedure
Both the preoperative preparation and the intervention were standardized. Patients underwent orthograde bowel lavage with polyethylene glycol and received perioperative antibiotic prophylaxis with an aminopenicillin or a cephalosporin plus metronidazole; ampicillin/sulbactam has been used since 2003. Anterior rectal resection was performed according to oncological principles. Total mesorectal excision (TME) was carried out after central ligation of the inferior mesenteric artery and radical lymphadenectomy.
Tumors less than 2 cm from the dentate line were treated by abdominoperineal rectal extirpation with placement of an omental plug to fill the true pelvis. Multilayer closure of the pelvic floor was performed after inserting two 16ch Redon drainage tubes to drain the true pelvis.
Intersphincteric rectal resection was performed for tumors more than 2 cm above the dentate line if the rectum below the tumor could not be closed by a linear stapler. Continuity was restored by colon pouch construction with stapling of colopouch-rectal and suturing of colopouchanal anastomoses. A protective stoma and pelvic drains were routinely used. The two groups did not differ with regard to intraoperative complications or operating time.
Definition of anastomotic leak
Only clinically manifest and thus relevant anastomotic leaks were recorded. In such cases, fecal matter was discharged from the pelvic drains, surgical wound or vagina or the leaks were detected by computed tomography (CT) with rectal contrast. Indications for CT were: clinical deterioration, abnormal abdominal findings, putrid rectal discharge, turbid drain discharge, and air passage through the drain.
Definition of perineal wound healing problems
Here the term "perineal wound healing problems" subsumes the following manifestations: perineal wound infection, sacral abscess, delayed wound healing or necrosis with subsequent dehiscence (Figure 1 ). 
Statistical analysis
The SPSS computer program was used for statistical analysis. Data were analyzed with the Wilcoxon test, Fisher's exact test and the chi-square test. Differences with 5% error probability (p0.05) were considered statistically significant.
Power calculations for Fisher's exact test were done by drawing 1000 random samples from the binomial distribution. The calculations were implemented and executed using the statistical language R.
Results
The two groups had comparable patient-, tumor-and therapy-related characteristics. Rectal resections were performed in over 80%. Rectal extirpation was necessary in 19% of patients in Group I (adjuvant CRT) and 16% of those in Group II (neoadjuvant CRT) ( Table 1 ).
The rate of anastomotic leaks did not differ (Group I vs. II: 10% vs. 11%). The two groups also had a comparable rate of postoperative bleeding, wound dehiscence (burst abdomen) and abdominal wall abscesses. However, a significant difference was found in the rate of perineal wound healing problems after rectal extirpation (Group I vs. II: 5% vs. 36%, p0.016) ( Table 2) .
Nonsurgical complications did not differ between the two groups ( Table 2) . While no patient died in Group I, lethality amounted to 1.5% (2/138) in Group II. One patient died as a result of an anastomotic leak, and the other one succumbed to aspiration pneumonia (Table 2) . 
Discussion
Neoadjuvant CRT has gained acceptance in the treatment of middle and lower third rectal cancer (UICC stage II and III), and various studies have examined its impact on the postoperative complication rate. Some of them deal only with complications after rectal resection [3] [4] [5] [10] [11] [12] [13] , others with those after rectal extirpation [6] [7] [8] [9] 14] (Table  3) .
It is remarkable that all but two [4, 12] of the studies compare the complication rate of a neoadjuvant CRT group with that of a control group submitted to surgery alone without any other form of multimodal therapy. However, the alternative to neoadjuvant CRT would be adjuvant therapy in a multimodal setting. Such a control group is used only in the two studies [4, 12] and in the present investigation (Table 3 ).
The type of neoadjuvant CRT is another aspect to be considered when interpreting the data. Short-course radiation therapy, for example, is associated with a markedly increased postoperative complication rate if surgery is performed outside the noncritical interval of 3 to 10 days thereafter [17] . However, the rate of anastomotic leaks and perineal wound healing problems also appears to be significantly increased after long-course radiation therapy if there is a short interval between neoadjuvant CRT and surgery. Kerr et al. conclude that delaying surgery beyond 8 weeks after neoadjuvant CRT reduces postoperative morbidity without compromising the prognosis [18] .
It is noteworthy that three of the twelve studies cited in Table 3 fail to provide substantial data on the type of neoadjuvant CRT. Short-course radiation was used in two and conventional fractionated radiation in seven of the nine other studies. Thus they can only be compared to a limited extent.
The rate of anastomotic leaks in the present study was 11% in the neoadjuvant and 10% in the adjuvant group.
Other groups also reported similar results [4, 10, 11] . Only two of the seven studies found a significant difference from the neoadjuvant group in terms of the anastomotic leak rate [5, 13] (Table 3) .
Various studies have identified neoadjuvant CRT as an independent risk factor for anastomotic leak [5, 19, 20] . However, there are also numerous studies demonstrating that neoadjuvant CRT does not increase the risk of anastomotic leak [21] [22] [23] [24] [25] . The definition of "perineal wound healing problems" was based on the literature in which "perineal wound infections" or "perineal wound complications" are discussed [6] [7] [8] [9] 14] . It is noteworthy that, despite all methodological reservations regarding the control group and the type of radiation therapy, the rate of perineal wound healing problems after neoadjuvant CRT is significantly increased in all but one study. It ranges from 14.7 to 47% in the neoadjuvant group as opposed to 5-23% in the respective control group (Table 3) .
Apparently neoadjuvant CRT additionally compromises the already problematic wound healing after rectal extirpation, since it leads to cell death and progressive occlusive vasculitis not only in the tumor but also in the tissue surrounding it [7] .
Conclusions
Compared to patients who were primarily operated and received adjuvant CRT, neoadjuvant CRT: i) does not increase the anastomotic leak rate; ii) increases the rate of perineal wound healing problems; iii) does not increase postoperative lethality. Abbreviations: n.d.= no data; neoadj. = neoadjuvant CRT; contr. = control group (no CRT except *(adjuvant CRT as control group)); + = significantly increased; = = no difference.
